Medical Devices Startups
6,252 companies tagged Medical Devices, with their investors and founders.
Joerns manufactures integrated beds, surfaces, and lifts designed to improve clinical outcomes and reduce caregiver injury risk in healthcare settings. The company positions its products as a cohesive system to enhance workforce stability, patient care quality, and financial performance for healthcare facilities.
2 investors
Jupiter Endovascular develops the Vertex Pulmonary Embolectomy System, a catheter-based device with Transforming Fixation technology for treating pulmonary embolism and other cardiovascular conditions. The company serves interventional cardiologists and healthcare institutions treating underserved cardiac patient populations.
2 investors
Kanaphterapeutics is a pharmaceutical company developing synthetic drugs and antibody-based therapeutics for cancer treatment using proprietary human genome analysis and ADC (antibody-drug conjugate) technologies.
2 investors
Kangstem Biotech is a South Korean biotechnology company developing stem cell-based therapeutics for rare and intractable diseases, including its FURESTEM-OA product for osteoarthritis. It also operates a CDMO (contract development and manufacturing) business and conducts related R&D.
2 investors
Kardi Ai provides long-term heart rhythm monitoring through a wearable chest strap and AI-powered mobile application certified as a medical device under European regulations. The service is designed for consumers seeking preventive cardiac care and arrhythmia detection with physician-reviewed ECG analysis.
2 investors
Kardigan develops targeted cardiovascular treatments through a discovery and translational research platform, with a pipeline of late-stage drug candidates aimed at functional cures for cardiovascular disease. The company integrates AI and real-world data to advance clinical development across multiple underserved cardiovascular conditions.
2 investors
Kare Chemical Technologies is a pharmaceutical technology company using a patented catalytic process to convert limonene, a citrus by-product, into high-purity CB1 and CB2 receptor ligands for drug development. It develops non-psychoactive therapeutic candidates aimed at safer alternatives to opioids and next-generation metabolic therapies.
2 investors
Karis Bio develops therapies based on human induced pluripotent stem cells (hiPSCs) to treat cardiovascular diseases, with initial focus on peripheral arterial disease and critical limb ischemia. The company targets vasculogenesis-related conditions such as ischemic heart disease, diabetic retinopathy, diabetic neuropathy, and wound healing.
2 investors
A biopharmaceutical company developing targeted cancer drugs and related therapies. The company focuses on drug discovery, clinical development, and commercialization to address unmet oncology needs in China and globally.
2 investors
KelSie Biotech is a biotechnology company developing and commercializing drug-delivery technologies licensed from Sievers Biotech, including a Bubble Drying Process, sublingual wafers, and dry powder inhalable products. The company holds worldwide rights to formulate, sell, and sublicense finished products based on this technology and intellectual property.
2 investors
Kenai Therapeutics develops iPSC-derived cell therapies and gene-modified medicines for neurodegenerative diseases, particularly Parkinson's disease, leveraging induced pluripotent stem cell technology to replace damaged neurons and restore neural function.
2 investors
Khartis is a drug discovery company developing oral therapies for patients with immune-mediated and chronic diseases. It operates in the biopharmaceutical and therapeutics sector.
2 investors
Kind Biotechnology develops the ION platform, which uses artificial genomic constructs to grow interconnected peripheral organs for xenotransplantation. The company aims to address organ scarcity in transplant medicine to treat age-related organ failure and extend healthy human lifespan.
2 investors
Kinexcs builds AI and wearable-sensor solutions for musculoskeletal recovery and rehabilitation, including KIMIA Recover, a post-surgical knee recovery management system with a smart wearable device. It serves patients recovering from orthopedic surgery, injuries, or joint pain through at-home assessment, personalized digital therapy, and remote monitoring.
2 investors
Kiniciti is a platform company that operates cell and gene therapy-focused life science businesses, including Cellistic for iPSC-based manufacturing technologies and Ncardia for human iPSC products and drug discovery services. The company serves therapeutic developers and pharmaceutical companies seeking scalable cell therapy manufacturing and drug discovery solutions.
2 investors
Kinometrix develops machine learning-based risk assessment tools for clinicians to identify patients at high risk of falls and prevent patient harm in healthcare settings. The platform integrates with electronic health records to support clinical decision-making without disrupting workflows.
2 investors
Kivo is a document management system for life sciences organizations that ensures GxP compliance through 21 CFR Part 11 e-signatures, access controls, and audit trails. The platform integrates DocuSign and Microsoft Office to support collaborative authoring, approval workflows, training assignments, and real-time compliance reporting.
2 investors
KIYATEC develops 3D Predict, a tumor-specific testing platform that uses patient-derived tumor cells to predict how individual cancers respond to therapies. It serves oncologists and cancer patients in the precision oncology and diagnostics space.
2 investors
KLOwen Orthodontics builds a full custom digital orthodontic system, including a custom bracket portfolio, cloud-based treatment planning software, a digital lab, and 3D-printed indirect bonding trays. It serves licensed orthodontists, aiming to reduce treatment time and the number of patient appointments.
2 investors
Koite Health develops patented dual-light technology for dental care and oral health treatments, offering products like Lumoral for both preventive and therapeutic use alongside a subscription tablet line. The company serves dental professionals and consumers in a €20 billion addressable market segment, with expansion potential into mucositis treatment.
2 investors
Kometa Bio develops dental surgical devices, specifically the Smart Dentin Grinder, which processes autologous dentin for bone augmentation procedures in dental practice.
2 investors
Krystal Biotech discovers, develops, and commercializes genetic medicines, including gene therapy programs for rare diseases such as dermatological conditions. The company operates across the US, Europe, and Japan.
2 investors
Kupando is a biopharmaceutical company developing TLR 4/7 agonists that stimulate innate immunity for use in oncology and infectious diseases. Its lead candidate KUP101 combines a TLR4 and a TLR7 agonist in a liposomal formulation for treating solid tumors and preventing infectious diseases.
2 investors
Kypha develops clinical diagnostic tests for immune system biomarkers, particularly complement activity markers, and provides solutions for real-time immune insights across therapeutic areas. The company serves biopharma firms, clinical laboratories, and medical institutions through a network of clinical collaborators and research partners.
2 investors